These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 39234248)

  • 1.
    Song DM; Shen T; Feng K; He YB; Chen SL; Zhang Y; Luo WF; Han L; Tong M; Jin Y
    Front Immunol; 2024; 15():1419126. PubMed ID: 39234248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
    Front Immunol; 2023; 14():955949. PubMed ID: 37006317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCGA Database-Based Screening of Tumor Microenvironment Immunomodulators Related to Bladder Cancer Prognosis.
    Ye JN; Gan MP; Wu XL; Dong Z; Mai HH
    Ann Clin Lab Sci; 2024 May; 54(3):299-312. PubMed ID: 39048164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer.
    Wang J; Tan Z; Huang Y; Li C; Zhan P; Wang H; Li H
    Aging (Albany NY); 2024 Jul; 16(14):11385-11408. PubMed ID: 39033778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Shared Gene Signatures and Molecular Mechanisms between Bladder Urothelial Carcinoma and Metabolic Syndrome.
    Li C; Wan Z; Deng Q; Li Z; Wang Y
    Arch Esp Urol; 2023 Oct; 76(8):605-621. PubMed ID: 37960960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
    Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X
    Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics.
    Liu J; Wu P; Lai S; Wang J; Wang J; Zhang Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16885-16904. PubMed ID: 37740761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated transcriptome analysis of CSE1L regarding poor prognosis and immune infiltration in bladder urothelial carcinoma and experimental verification.
    Liu R; Ma J; Zhang Y; Zhou Z
    Front Immunol; 2024; 15():1449251. PubMed ID: 39430746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer.
    Liu W; Wei C; He Q; Chen Z; Zhuang W; Guo Y; Xue X
    Sci Rep; 2024 Aug; 14(1):19025. PubMed ID: 39152248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
    Sun S; Wang Y; Wang J; Bi J
    J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.
    Mi Y; Wang X
    J Environ Pathol Toxicol Oncol; 2022; 41(3):1-12. PubMed ID: 35993952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
    Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W
    Hereditas; 2019; 156():24. PubMed ID: 31333338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data.
    Xu Y; Wu G; Li J; Li J; Ruan N; Ma L; Han X; Wei Y; Li L; Zhang H; Chen Y; Xia Q
    Biomed Res Int; 2020; 2020():8283401. PubMed ID: 32047816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cell division cycle 20 as a candidate biomarker and potential therapeutic target in bladder cancer using bioinformatics analysis.
    Shen P; He X; Lan L; Hong Y; Lin M
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer.
    Yan Z; Liu Y; Wang M; Wang L; Chen Z; Liu X
    Sci Rep; 2024 Jun; 14(1):14667. PubMed ID: 38918587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer.
    Huang Z; Wang Z; Xu C; Yan Y; Cao X; Zhang F; Shen B
    Int J Med Sci; 2024; 21(8):1447-1460. PubMed ID: 38903931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.